ACON - Aclarion, Inc.

3.27
0.210   6.422%

Share volume: 108,197
Last Updated: 03-06-2026
Healthcare/Services – Health: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$3.06
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 43%
Dept financing 24%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
14.34%
1 Month
18.48%
3 Months
-44.39%
6 Months
-53.94%
1 Year
136.96%
2 Year
871.19%
Key data
Stock price
$3.27
P/E Ratio 
0.00
DAY RANGE
$2.98 - $3.30
EPS 
-$12.55
52 WEEK RANGE
$0.49 - $15.08
52 WEEK CHANGE
$174.79
MARKET CAP 
4.368 M
YIELD 
N/A
SHARES OUTSTANDING 
671.371 K
DIVIDEND
$0.00
EX-DIVIDEND DATE
03-28-2025
NEXT EARNINGS DATE
05-14-2025
BETA 
-0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$98,747
AVERAGE 30 VOLUME 
$78,519
Company detail
CEO: Brent Ness
Region: US
Website: aclarion.com
Employees: 7
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Aclarion, Inc. develops software application for magnetic resonance spectroscopy (MRS) in the U.S. It offers NOCISCAN-LS Post-Processor suite, NOCICALC-LS, and NOCIGRAM-LS. The company was formerly known as Nocimed, which changed its name to ACLarion in December 2021.

Recent news